Organization
Medical University of Vienna, Vienna, Austria
12 abstracts
Abstract
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW.Org: University Medical Center Mainz, University Grenoble Alpes, CHU Grenoble Alpes, Institute for Advanced Biosciences, Kindai University Faculty of Medicine, Osaka-Sayama, Japan,
Abstract
“WHEN YOU READ THIS, YOU REALLY FEEL OLD!” PERSPECTIVES OF YOUNG PEOPLE WITH INFLAMMATORY ARTHRITIS ON PATIENT REPORTED OUTCOME MEASURES FROM A EUROPEAN QUALITATIVE STUDYOrg: Medical University of Vienna, Vienna, Austria, University of Perugia, Perugia, Italy, UHC Zagreb and University of Zagreb School of Medicine, Zagreb, Croatia, Patient research Partner, Amsterdam, Netherlands, LUMC, Leiden, Netherlands,
Abstract
“BACK TO BEING NORMAL”: THE PATIENT PERSPECTIVE ON REMISSION IN RHEUMATOID ARTHRITIS Org: VU University Medical Center, Amsterdam, Netherlands, University of the West of England, Bristol, United Kingdom, Rheumatology, Medical University of Vienna, Vienna, Austria, Bristol Royal Infirmary, Bristol, United Kingdom, Medical University of Vienna, Vienna, Austria,
Abstract
2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUSOrg: University of Perugia, Perugia, Italy, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany, Leiden University Medical Center, Leiden, Netherlands, University of Padova, Padova, Italy, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom,
Abstract
AUTOSCORA: DEEP LEARNING TO AUTOMATE SCORING OF RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITISOrg: Medical University of Vienna, Vienna, Austria,
Abstract
A RANDOMISED, DOUBLE-BLIND, PHASE III STUDY COMPARING SB2, AN INFLIXIMAB BIOSIMILAR, TO THE INFLIXIMAB REFERENCE PRODUCT (REMICADE®) IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY Org: Daegu Catholic University Medical Center, Daegu, Korea, Republic Of, Clinical Center Banja Luka, Banja Luka, Bosnia and Herzegovina, Medica Pro Familia, Gdynia, Poland, MHAT “Dr. Ivan Seliminski”, AD, Sliven, Bulgaria, MEDICAL PLUS s.r.o, Uherske Hradiste, Czech Republic,
Abstract
ASSOCIATION BETWEEN FLARE AND RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS Org: Medical University of Vienna, Vienna, Austria, Pfizer, Collegeville, United States,
Abstract
ANTAGONIZING ENDOSOMAL TOLL-LIKE RECEPTORS DIMINISHES INFLAMMATORY ARTHRITIS Org: Medical University of Vienna, Vienna, Austria, Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany,
Abstract
A pooled analysis of three tnf-Α inhibitor biosimilar studies in patients with rheumatoid arthritis comparing radiographic progression by disease activity statesOrg: Medical University of Vienna, Vienna, Austria, Brigham and Women’s Hospital, Boston, USA, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, UK, Mount Sinai Hospital, Toronto, Canada, Stanford University Medical Center, Stanford, USA,
Abstract
ASSOCIATIONS BETWEEN OCCUPATIONAL BALANCE AND IMMUNOLOGY: DIFFERENCES IN HEALTH CONDITIONS, EMPLOYMENT STATUS UND GENDER Org: Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Internal Medicine III Division of Rheumatology, Medical University of Vienna, Vienna, Austria, Swiss Paraplegic Group, Nottwil, Switzerland,
Abstract
BASELINE CHARACTERISTICS OF SYSTEMIC SCLEROSIS PATIENTS WITH BORDERLINE MEAN PULMONARY ARTERY PRESSURE: POST-HOC ANALYSIS FROM THE DETECT STUDY Org: University of Michigan, Ann Arbor, United States of America, University Hospital Zurich, Zurich, Switzerland, Royal Free Hospital, London, United Kingdom, University Hospital Heidelberg, Heidelberg, Germany, Medical University of Vienna, Vienna, Austria,
Abstract
Biologic dmards and psoriatic arthritis in europe in 2016/2017: characteristics of patients starting tnf-inhibitors or ustekinumab in the ongoing psabio observational cohort studyOrg: Sorbonne Université, Paris, France, St. Paul (Agios Pavlos) Hospital, Thessaloniki, Greece, Janssen-Cilag B.V., Breda, Netherlands, University Hospitals Leuven, Leuven, Belgium, Fondazione Policlinico Gemelli-Catholic University of the Sacred Heart, Rome, Italy,